Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

824 public trials 109 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Cancer

NCT00100672

Conditions: Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +2 more
Locations: premiere Oncology-Arizona Scottsdale, Arizona, United States

Premiere Oncology-Santa Monica Santa Monica, California, United States

View Trial Details

Completed

A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors

NCT00783328

Conditions: Neoplasms
Locations: Pfizer Investigational Site Sunto-gun, Shizuoka, Japan

View Trial Details

Completed

An Efficacy and Safety Study for Epoetin Alfa (PROCRIT) in Cancer Patients Not Receiving Chemotherapy or Radiation

NCT00210587

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Not specified

View Trial Details

Completed

Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers

NCT00740922

Conditions: Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +12 more
Locations: Not specified

View Trial Details

Completed

A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy

NCT00216541

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug

NCT00269997

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy

NCT00266617

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Not specified

View Trial Details

Completed

PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy

NCT00388336

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Not specified

View Trial Details

Completed

Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia

NCT00270049

Conditions: Anemia, Cancer, Chronic Disease, +18 more
Locations: Not specified

View Trial Details

Completed

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

NCT00050427

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations: Not specified

View Trial Details